Literature DB >> 31676561

Dendritic Cells Drive Osteosarcomagenesis through Newly Identified Oncogene and Tumor Suppressor.

Kevin B Jones1.   

Abstract

GRM4, a GWAS-suspected tumor suppressor, is tested in a mouse model of osteosarcomagenesis as well as the putative oncogene it suppresses, IL23. Both are expressed in and exert the bulk of their influence among tumor-infiltrating myeloid-derived antigen-presenting cells, rather than osteosarcoma cells.See related article by Kansara et al., p. 1511. ©2019 American Association for Cancer Research.

Entities:  

Mesh:

Year:  2019        PMID: 31676561     DOI: 10.1158/2159-8290.CD-19-0994

Source DB:  PubMed          Journal:  Cancer Discov        ISSN: 2159-8274            Impact factor:   39.397


  2 in total

Review 1.  Immune Microenvironment in Osteosarcoma: Components, Therapeutic Strategies and Clinical Applications.

Authors:  Tianyi Zhu; Jing Han; Liu Yang; Zhengdong Cai; Wei Sun; Yingqi Hua; Jing Xu
Journal:  Front Immunol       Date:  2022-06-01       Impact factor: 8.786

2.  A Novel Predictive Model Associated with Osteosarcoma Metastasis.

Authors:  Han Zhang; Guanhong Chen; Xiajie Lyu; Chun Rong; Yingzhen Wang; Ying Xu; Chengyu Lyu
Journal:  Cancer Manag Res       Date:  2021-11-09       Impact factor: 3.989

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.